Radiotherapeutisch Instituut Friesland (RIF) to acquire Elekta Unity for innovative cancer treatment
STOCKHOLM, April 23, 2020 – Elekta (EKTA-B.ST) announced today that Radiotherapeutisch Instituut Friesland in Leeuwarden, the Netherlands, has ordered advanced radiation therapy equipment, including Elekta Unity MR-Linac, three Versa HD™ linear accelerators, software and service for all equipment over five years.The new Elekta systems will replace four existing linacs, which the institute has used to treat about 2,500 patients annually. The Dutch market is showing good momentum in the adoption of Elekta Unity, putting the Netherlands at the forefront of cancer care using magnetic resonance radiation therapy. Versa HD enables high definition dynamic radiosurgery (HDRS), offering stereotactic body radiotherapy (SBRT) reliability with anatomically guided accuracy and efficiency.
Renato Leite, Elekta’s Head of Region Europe, says: “This is wonderful news for cancer patients in Friesland, in the north of the Netherlands, as they will have access to state-of-the-art technology designed with the patient in mind. It is also gratifying to have the continued trust of our long-standing customer, Radiotherapeutisch Instituut Friesland.”
Annerie Slot, Director and Radiation Oncologist at RIF says: “I am very pleased that the RIF has purchased Elekta Unity. By using MR imaging with every fraction, a highly individualized radiation plan can be offered to our patients. We look forward to further collaboration with Elekta and other Unity users for the benefit of our patients.”
The order was booked in the fourth quarter of Elekta’s fiscal year 2019/20, with the first installations to begin before July 2020. The Unity installation is scheduled for late 2021.
# # #
For further information, please contact:
Mattias Thorsson, Head of Corporate Communications and Public Affairs
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
Raven Canzeri, Global Public Relations Manager, Elekta
Tel: +1 770-670-2524, e-mail: raven.canzeri@elekta.com
Time zone: ET: Eastern Time
About Elekta Unity
Elekta Unity is a state-of-the-art MR-Linac that is redefining a new standard for personalized radiation therapy based on real-time high-resolution anatomical and biological MRI at the point-of-care. Elekta Unity combines two technologies – a high-field 1.5 Tesla (T) Philips MRI scanner and a best-in-class 7MV linear accelerator – together with breakthrough online dose replanning software. The 1.5T MRI enables pre-treatment visualization of daily patient anatomy with superior soft-tissue contrast and high anatomical detail, with the benefit of zero imaging-related ionizing radiation dose to the patient. The online dose replanning software then provides the ability to reshape the treatment dose in minutes based on daily changes in shape, size and position of the tumor and surrounding healthy anatomy followed by accurate dose delivery with real-time tumor visualization.
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
